NCT01036061View on ClinicalTrials.gov

GSK618334 Repeat Dose Study

PHASE1CompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

September 28, 2009

Primary Completion Date

February 17, 2010

Study Completion Date

February 17, 2010

Conditions

Substance Dependence

Interventions

DRUG

GSK618334 Low Dose

GSK618334 low dose

DRUG

GSK618334 PET subjects

PET subjects

DRUG

GSK618334 Medium Dose

Medium Dose

DRUG

GSK618334 High Dose

GSK618334 High Dose

Trial Locations (1)

NW10 7EW

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY